Status:
COMPLETED
Serum Progesterone on the Day of Thawed Embryo Transfer and Pregnancy Rate After an Artificial Endometrial Preparation
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
IVF
Eligibility:
FEMALE
18-38 years
Phase:
NA
Brief Summary
To determine if different serum Progesterone levels on FET day are associated with different clinical pregnancy rates (CPR), and if increasing dosage of vaginal Progesterone in cases of lower serum Pr...
Detailed Description
Over the past decade, the use of frozen-thawed embryo transfer (FET) has risen around the globe. There is no consensus which mode of FET is superior, either natural cycle (NC) or artificial cycle (AC)...
Eligibility Criteria
Inclusion
- women between age 18-38 undergoing FET in AC
- with body mass index (BMI) \< 35 kg/m2
- a triple layer endometrium \>6.5 mm after exogenous estrogen administration
- 1-2 good quality day 3 or 5 FET.
Exclusion
- women with recurrent pregnancy losses (e.g. 2 abortions beyond 12th week or 3 abortions before 12th week)
- recurrent implantation failure (e.g. unsuccessful implantation of ≥4 good quality embryos)
- severe male factor (sperm concentration \<5 million/ml), or presence of hydrosalpinx.
Key Trial Info
Start Date :
March 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04278508
Start Date
March 9 2020
End Date
June 6 2022
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 381000